Evidence map›Paper›PMID 38680500›Full record

ArticleFrontiers in immunology2024

Myeloid A20 is critical for alternative macrophage polarization and type-2 immune-mediated helminth resistance.

Ioanna Petta, Marie Thorp, Maarten Ciers, Gillian Blancke, Louis Boon, Tim Meese, Filip Van Nieuwerburgh, Andy Wullaert, Richard Grencis, Dirk Elewaut and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Frontiers in immunology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ioanna PettaDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Marie ThorpDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Maarten CiersDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Gillian BlanckeDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Louis BoonJJP Biologics, Warsaw, Poland.
Tim MeeseLaboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
Filip Van NieuwerburghLaboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.
Andy WullaertDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Richard GrencisLydia Becker Institute of Immunology and Inflammation, Wellcome Centre for Cell Matrix Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Dirk ElewautDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Geert van LooVIB Center for Inflammation Research, Ghent, Belgium.
Lars VereeckeDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Funding

Wellcome Trust Z10661/Z/18/Z
6 · The paper itself

Abstract

Background: Protective immunity against intestinal helminths requires induction of robust type-2 immunity orchestrated by various cellular and soluble effectors which promote goblet cell hyperplasia, mucus production, epithelial proliferation, and smooth muscle contractions to expel worms and re-establish immune homeostasis. Conversely, defects in type-2 immunity result in ineffective helminth clearance, persistent infection, and inflammation. Macrophages are highly plastic cells that acquire an alternatively activated state during helminth infection, but they were previously shown to be dispensable for resistance to Methods: We use the in vivo mouse model A20myel-KO, characterized by the deletion of the potent anti-inflammatory factor A20 (TNFAIP3) specifically in the myeloid cells, the excessive type-1 cytokine production, and the development of spontaneous arthritis. We infect A20 Results: We show that proper macrophage polarization is essential for helminth clearance, and we identify A20 as an essential myeloid factor for the induction of type-2 immune responses against Conclusions: We hereby identify A20 as a critical myeloid factor for correct macrophage polarization and appropriate adaptive mucosal immunity in response to helminth and enteric bacterial infection.

Indexed as

Disease ResistanceMacrophage ActivationMacrophagesTrichuriasisTumor Necrosis Factor alpha-Induced Protein 3AnimalsCytokinesDisease Models, AnimalImmunity, InnateMiceMice, Inbred C57BLMice, KnockoutMyeloid CellsTh2 CellsTrichurisCytokinesTnfaip3 protein, mouseTumor Necrosis Factor alpha-Induced Protein 3A20 (TNFAIP3)adaptive immunityhelminth infectionimmunity to parasitesinnate immunityintestinal immunitymacrophage polarizationtype-2 response

Identifiers

PMID38680500
PMCPMC11045979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.